Displaying 941 - 960 of 1097
PIP Number | Active Substance | Conditions / Indications | Invented Name | Therapeutic area | Decision Type | Compliance Check | Compliance outcome | Date Published Sort ascending |
---|---|---|---|---|---|---|---|---|
PIP Number MHRA-100315-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100316-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type W: decision granting a waiver in all age groups for the listed condition(s). | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100364-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100304-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100305-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100267-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100266-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100270-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100244-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100224-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100396-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type W: decision granting a waiver in all age groups for the listed condition(s). | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100293-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100265-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100199-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type W: decision granting a waiver in all age groups for the listed condition(s). | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100165-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100109-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100100-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100062-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100091-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100027-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |